IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Trial record 64 of 23042 for:
"Communicable Diseases"
Infections After Renal Transplantation: Diseases Pattern in Hong Kong
This study has been completed.
Sponsor:
Hospital Authority, Hong Kong
Information provided by:
Hospital Authority, Hong Kong
ClinicalTrials.gov Identifier:
NCT00498017
First received: July 6, 2007
Last updated: June 14, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Infections are the most feared complications developing in patient who had had kidney transplantation. The aim of this study is to document the local disease pattern among this group of patients.
| Condition |
|---|
| Kidney Transplantation Infection |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Infections After Renal Transplantation: Diseases Pattern in Hong Kong |
Resource links provided by NLM:
Further study details as provided by Hospital Authority, Hong Kong:
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Sampling Method: | Non-Probability Sample |
Study Population
Over a period of 4.5 years, between 1/1/2000 and 30/6/2005, there were totally 58 new cases in our renal transplantation clinic. 36 of them were male, 22 of them were female (Male to female ratio is 1.64:1). All were single-organ recipients. Majority of them (57/58 or 98.3%) were receiving their first renal transplantation, the only exception was a women receiving her second renal transplantation during the study period. Majority (57/48 or 98.3%) of them were cadaveric renal transplantation (CRT). One living-related renal transplantation (LDRT) had been performed in Hong Kong during the study period. Majority of the renal transplantation were performed in Mainland China (48/58 or 82.8%), whilst the remaining 10 operations (17.2%) were performed in Hong Kong.
Criteria
Inclusion Criteria:
- All living-related or cadaveric renal transplantation episodes (including preemptive ones) performed in the Hong Kong Special Administration Region (HKSAR), Mainland China or overseas during the period 1/1/2000 to 30/6/2005
Exclusion Criteria:
- multiple organ recipients, incomplete records and lost to follow-up, including those cases who have been taken over by other renal centres
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00498017
Please refer to this study by its ClinicalTrials.gov identifier: NCT00498017
Locations
| China | |
| Caritas Medical Centre | |
| Hong Kong, China | |
| Princess Margaret Hospital | |
| Hong Kong, China | |
Sponsors and Collaborators
Hospital Authority, Hong Kong
Investigators
| Principal Investigator: | Sze Kit Yuen, Dr | Department of Medicine & Geriatrics, ICU, Caritas Medical Centre |
More Information
Additional Information:
| ClinicalTrials.gov Identifier: | NCT00498017 History of Changes |
| Other Study ID Numbers: |
KW/EX/06-044 HARECCTR0500060 |
| Study First Received: | July 6, 2007 |
| Last Updated: | June 14, 2011 |
Keywords provided by Hospital Authority, Hong Kong:
|
Infections |
Additional relevant MeSH terms:
|
Infection Communicable Diseases |
ClinicalTrials.gov processed this record on June 23, 2017